Alzheimer's drug trial halted early – what we know
Disease control
Terminated
This study tested a drug called varoglutamstat (PQ912) in people with early Alzheimer's disease. The goal was to see if it is safe and if it could slow memory and thinking problems. The trial was stopped early, so we have less information than planned. About 112 people took part,…
Phase: PHASE2 • Sponsor: Vivoryon Therapeutics N.V. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC